US stock · US markets · public data

BIIB

Biogen Inc · Healthcare

Reference price$232.83Updated according to the public source
P/E41.36
P/B1.82
ROE4.58%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 34.4 B
Volume (shares)1,947,121
SectorHealthcare
Overview

About BIIB

Demonstrações públicas consolidadas + SEC Company Facts

Biogen Inc (BIIB) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$9,835,600,000.00$9,675,900,000.00$9,890,600,000.00—
Gross Profit————
Operating Income————
Net Income$1,161,100,000.00$1,632,200,000.00$1,292,900,000.00—
EPS Diluted$7.97 / share$11.18 / share$8.79 / share—

Balance sheet

Account2023202420252026
Total Assets$26,844,800,000.00$28,049,300,000.00$29,439,500,000.00—
Total Liabilities$12,045,400,000.00$11,333,300,000.00$11,182,700,000.00—
Total Equity$14,799,400,000.00$16,716,000,000.00$18,256,800,000.00—
Long-term Debt$6,938,200,000.00$6,295,800,000.00$6,286,800,000.00—
Shares Outstanding144,485,646 shares145,360,798 shares146,374,937 shares146,758,528 shares
Cash & Investments————
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$1,547,200,000.00$2,875,500,000.00$2,204,600,000.00—
Capital Expenditures$277,000,000.00$153,700,000.00$153,800,000.00—
Free Cash Flow$1,270,200,000.00$2,721,800,000.00$2,050,800,000.00—
FAQ

Frequently asked questions

What is the price of BIIB?

The reference price available for BIIB is $232.83.

What is the P/E of BIIB?

The P/E ratio of BIIB is 41.36. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of BIIB?

The P/B of BIIB is 1.82. This compares price with reported book value per share.

What is the ROE of BIIB?

The ROE (Return on Equity) of BIIB is 4.58%. This relates the reported net result to shareholders' equity.

What is the dividend yield of BIIB?

The dividend yield of BIIB is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of BIIB?

The market capitalization of BIIB is US$ 34.4 B.

What sector is BIIB in?

BIIB operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.